Texas-based Vizzhy Inc., a firm focussing on healthcare innovation leveraging multi-omics, is in the process of building what is claimed to be the world’s first and largest multi-omics-based Generative AI platform on holistic health to help the common man, medical professionals and researchers.
Vizzhy’s a team of 40 data scientists, medical professionals and researchers and deep tech experts based in Bengaluru will be working on this project. To run the project, the company has imported the NVIDIA DGX H100, which claims to be the AI powerhouse and the foundation of NVIDIA DGX SuperPOD, that helps enterprises solve the biggest challenges with AI through its high performance.
Multi-omics (multiple omics) offer possibilities of holistic discovery across multiple levels of biology. By combining multi-omics data, researchers will be able to get a deeper, holistic understanding of molecular changes happening in the human body, and therefore physicians would be able to treat all kinds of ailments more effectively with significantly less, but precise medication. Multi-omics involve a comprehensive analysis of biological data, integrating genomics, proteomics, transcriptomics, and metabolomics to unravel intricate disease mechanisms and advance personalised medicine.
